Ameet Mallik | executive |
Jose Carmona | executive |
Eric Schmidt | analyst |
Dingding Shi | analyst |
Michael Schmidt | analyst |
Lut Ming Cheng | analyst |
Welcome to the ADC Therapeutics Second Quarter 2024 Financial Results Conference Call. My name is Didi, and I will be your operator for today's call. [Operator Instructions]
I will now turn the call over to [ Marcy Graham ], Investor Relations Officer for ADCT. Marcy, you may begin.